Anaveon is a developing IL-2 complexes which selectively promote effector T cell functions.

Therapeutics

Anaveon

Anaveon's headquarters in Bottmingen, Switzerland

Andreas Katopodis

Pius Gutzwiller

Christoph Huber

Eduard Gasal

Stephanie Fernando

Arkadi Khait

Gary Phillips

The Clinical Operations Team at Anaveon is responsible for planning, executing, and overseeing clinical trials to evaluate the efficacy and safety of IL-2 complexes. This team ensures compliance with regulatory standards, coordinates trial logistics, manages data collection, and works closely with cross-functional teams to advance clinical development.

Clinical Operations Team

The Scientific Team at Anaveon focuses on advancing research and development of IL-2 complexes to selectively enhance effector T cell functions. This includes protein engineering, experimental design, and data analysis to drive innovations in immunotherapy treatments.

Scientific Team

The Leadership Team at Anaveon is responsible for setting the strategic direction and vision of the company, guiding the development of innovative IL-2 complexes. Comprising key executives with expertise in science, business, and operations, the team collaborates to drive research initiatives, secure funding, and forge partnerships, ensuring the successful progression of therapies that enhance effector T cell functions.

Leadership Team

The Medical Team at Anaveon is responsible for overseeing clinical development and medical strategy for IL-2 complexes that selectively enhance effector T cell functions. They design and manage clinical trials, analyze data, and ensure regulatory compliance to bring innovative therapies to market effectively and safely.

Anaveon

Org chart

Teams

Clinical Operations Team

Scientific Team

Leadership Team

Medical Team

Offices

Anaveon

Org chart

Teams

Clinical Operations Team

Scientific Team

Leadership Team

Medical Team

Offices

Related companies